EPIC Program Annual Data Tables 2004-2005: Table VII

Table VII
Ten Most Frequently Purchased Types of Drugs
by Therapeutic Classification*
Therapeutic Class Number
of Claims
Percent
of Claims
EPIC
Payments
Number of
Participants
Total4,825,74643.41%$307,230,274
BETA-ADRENERGIC BLOCKING AGENT819,4517.36%$23,031,335151,542
HMG-COA REDUCTASE INHIBITORS659,9845.94%$91,314,866150,138
DIURETICS632,0335.69%$4,621,125136,947
ANGIOTENSIN-CONVERTING ENZYME576,5385.19%$20,037,303110,002
PROTON-PUMP INHIBITORS393,4613.54%$70,823,95693,950
DIHYDROPYRIDINES378,7453.41%$27,034,28777,890
ANTIDEPRESSANTS372,8103.35%$26,529,68470,345
OPIATE AGONISTS342,3423.08%$14,192,48589,539
ANGIOTENSIN II RECEPTOR ANTAGO337,5283.04%$25,411,66071,419
THYROID AGENTS312,8542.81%$4,233,57359,643

* Table VII provides the percent of adjudicated claims for the program year (October 1, 2004 through September 30, 2005) as they fall into particular categories of Therapeutic Class.

** American Hospital Formulary Service® (AHFS) Pharmacologic-Therapeutic Classification.

*** This report contains the top ten drug classes; additional drug classes comprise the remainder of claims up to 100.00%.